巴克莱银行借道ETF布局港股创新药，恒生创新药指数年内上涨68%

环球网2025-07-04

【环球网财经综合报道】日前，华宝恒生港股通创新药精选ETF公布的上市交易公告书中，披露了持有人户数、持有人结构及前十名持有人。而截至6月30日，巴克莱银行持有该ETF达2000万份，占基金总份额的4.5997%，为第一大持有人。东方IC事实上，巴克莱银行并非首次涉足创新药ETF投资。2024年底，巴克莱银行便已买入华泰柏瑞恒生创新药ETF（QDII），彼时持有份额达8500万份，占总份额的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2548309323?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-04 10:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2548309323","market":"us","top_or_hot":-1,"title":"巴克莱银行借道ETF布局港股创新药，恒生创新药指数年内上涨68%","media":"环球网","content":"<div>\n<p>【环球网财经综合报道】日前，华宝恒生港股通创新药精选ETF公布的上市交易公告书中，披露了持有人户数、持有人结构及前十名持有人。而截至6月30日，巴克莱银行持有该ETF达2000万份，占基金总份额的4.5997%，为第一大持有人。东方IC事实上，巴克莱银行并非首次涉足创新药ETF投资。2024年底，巴克莱银行便已买入华泰柏瑞恒生创新药ETF（QDII），彼时持有份额达8500万份，占总份额的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704103321a4ce74ba&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>巴克莱银行借道ETF布局港股创新药，恒生创新药指数年内上涨68%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n巴克莱银行借道ETF布局港股创新药，恒生创新药指数年内上涨68%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-04 10:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704103321a4ce74ba&s=b><strong>环球网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>【环球网财经综合报道】日前，华宝恒生港股通创新药精选ETF公布的上市交易公告书中，披露了持有人户数、持有人结构及前十名持有人。而截至6月30日，巴克莱银行持有该ETF达2000万份，占基金总份额的4.5997%，为第一大持有人。东方IC事实上，巴克莱银行并非首次涉足创新药ETF投资。2024年底，巴克莱银行便已买入华泰柏瑞恒生创新药ETF（QDII），彼时持有份额达8500万份，占总份额的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704103321a4ce74ba&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4614","symbol_name":"Manus概念股","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704103321a4ce74ba&s=b","article_id":"2548309323","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704103321a4ce74ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2548309323","pubTimestamp":1751596268,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"而截至6月30日，巴克莱银行持有该ETF达2000万份，占基金总份额的4.5997%，为第一大持有人。东方IC事实上，巴克莱银行并非首次涉足创新药ETF投资。2024年底，巴克莱银行便已买入华泰柏瑞恒生创新药ETF，彼时持有份额达8500万份，占总份额的42.02%，同样位居第一大持有人之位。截至7月3日，恒生创新药指数年内上涨68.1%，成为市场瞩目的焦点。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4614":"Manus概念股","BK4550":"红杉资本持仓","BK4588":"碎股","BK4585":"ETF&股票定投概念","YANG":"三倍做空富时中国ETF-Direxion","BK4521":"英国银行股","FDN":"First Trust Dow Jones Internet I","BK4207":"综合性银行","BCS":"巴克莱银行"},"translate_title":"Barclays Bank uses ETFs to deploy innovative drugs in Hong Kong stocks, and the Hang Seng Innovative Drug Index rose 68% during the year","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BCS":1,"YANG":1,"FDN":1},"content_text":"【环球网财经综合报道】日前，华宝恒生港股通创新药精选ETF公布的上市交易公告书中，披露了持有人户数、持有人结构及前十名持有人。而截至6月30日，巴克莱银行持有该ETF达2000万份，占基金总份额的4.5997%，为第一大持有人。东方IC事实上，巴克莱银行并非首次涉足创新药ETF投资。2024年底，巴克莱银行便已买入华泰柏瑞恒生创新药ETF（QDII），彼时持有份额达8500万份，占总份额的42.02%，同样位居第一大持有人之位。截至7月2日，该基金自成立以来的收益率已超过56%。相比之下，近半年成立的其他创新药ETF持有人以券商、私募、个人投资者、企业年金为主。以银华国证港股通创新药ETF为例，其前十大持有人中券商占据7席；易方达恒生港股通创新药ETF前十大持有人中，个人投资者占据6席；工银瑞信国证港股通创新药ETF前十大持有人中，企业年金计划则占据9席。2025年以来，创新药板块表现亮眼，整体涨幅领先。截至7月3日，恒生创新药指数年内上涨68.1%，成为市场瞩目的焦点。此外，国家医保局、国家卫生健康委近日印发《支持创新药高质量发展的若干措施》，从加大创新药研发支持力度、支持创新药进入基本医保药品目录和商业健康保险创新药品目录、支持创新药临床应用、提高创新药多元支付能力、强化保障措施五个方面提出16条措施。（南木）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2548309323","isCrawlerRequest":true}